Clinical trial
Safety of Nasal Influenza Immunisation in Children With Asthma - The SNIFFLE-4 Study
NCT02866942 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Nasal Influenza Immunisation in Children With Asthma - The SNIFFLE-4 Study
- Lead sponsor
- Imperial College London
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- March 31, 2017
- Enrollment
- 479 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.